These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 5529547

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Role of heparin in the inactivation of thrombin, factor Xa, and plasmin by antithrombin III.
    Stürzebecher J, Markwardt F.
    Thromb Res; 1977 Dec; 11(6):835-46. PubMed ID: 146278
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Practical considerations on the measurement of low molecular weight heparin anti-Xa activity.
    Aiach M, Roncato M.
    Semin Thromb Hemost; 1985 Apr; 11(2):108-11. PubMed ID: 4035362
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Amidolytic antifactor Xa assays in the laboratory evaluation of heparin and low molecular weight fractions.
    Walenga JM, Bara L, Samama MM, Fareed J.
    Semin Thromb Hemost; 1985 Apr; 11(2):100-7. PubMed ID: 4035361
    [No Abstract] [Full Text] [Related]

  • 8. Simultaneous inactivation of thrombin and factor Xa by AT-III: influence of heparin.
    Odegård OR, Lie M.
    Thromb Res; 1978 Apr; 12(4):697-700. PubMed ID: 663903
    [No Abstract] [Full Text] [Related]

  • 9. Protection of factor Xa from neutralization by the heparin-antithrombin complex.
    Teitel JM, Rosenberg RD.
    J Clin Invest; 1983 May; 71(5):1383-91. PubMed ID: 6222069
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Reactivity of a hereditary abnormal antithrombin III fraction in the inhibition of thrombin and factor Xa.
    Tran TH, Bondeli C, Marbet GA, Duckert F.
    Thromb Haemost; 1980 Oct 31; 44(2):92-5. PubMed ID: 7455997
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Plasma antithrombin III: a quantitative assay of biological activity.
    Gitel SA, Wessler S.
    Thromb Res; 1975 Jul 31; 7(1):5-16. PubMed ID: 1154342
    [No Abstract] [Full Text] [Related]

  • 18. [Role of the liver in producing heat-stable antifactor Xa].
    Galian SL.
    Biull Eksp Biol Med; 1980 Jul 31; 89(7):7-9. PubMed ID: 7407374
    [Abstract] [Full Text] [Related]

  • 19. Molecular weight dependency of the heparin potentiated inhibition of thrombin and activated factor X. Effect of heparin neutralization in plasma.
    Andersson LO, Barrowcliffe TW, Holmer E, Johnson EA, Söderström G.
    Thromb Res; 1979 Jul 31; 15(3-4):531-41. PubMed ID: 494159
    [No Abstract] [Full Text] [Related]

  • 20. Antithrombin III and heparin.
    Barrowcliffe TW, Johnson EA, Thomas D.
    Br Med Bull; 1978 May 31; 34(2):143-50. PubMed ID: 350337
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.